Providers
All 178 in CA
PALM SPRINGS OPERATING COMPANY, LP
NPI 1861896805, organization, Palm Springs, CA, Skilled Nursing Facility
3
Evidence tier
network structure with a list link
- Part of provider network D1-00092, ranked 92 nationally.
score 60 of 100, rank 5506, $0 at stake
Provider networks
D1-00092 ranked 9280 providers around Hayward, CA: 6 hospices, 11 home health agencies, 63 nursing facilities.
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | PALM SPRINGS OPERATING COMPANY, LP (also PALM SPRINGS HEALTHCARE & REHABILITATION CENTER) |
| Type | Organization |
| Status | Active |
| NPI issued | October 20, 2014, last updated October 20, 2014 |
| Practice location | 277 S SUNRISE WAY, Palm Springs, CA 92262-6738, 760-327-8541 |
| Authorized official | ANDREA SAAVEDRA (Regional Financial Analyst) |
| Specialties | Skilled Nursing Facility (314000000X, primary, license 250000182 CA) |
In this area
178 providers in Riverside County, CA carry an indicator in the public record, with $225.2M at stake between them. The most common is more hours than a day holds, on 113 of them, followed by part of a provider network on 57. 5 are tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | PHLEBXPRESS Temecula, CA, ranked 20 | $45K |
|
| 1 | BABAR IQBAL MD INC Riverside, CA, ranked 267 | $13K |
|
| 1 | BABAR IQBAL Riverside, CA, ranked 268 | $13K |
|
| 1 | FERNANDO PALACIOS Wildomar, CA, ranked 334 | $4K |
|
| 1 | BORREGO COMMUNITY HEALTH FOUNDATION Lake Elsinore, CA, ranked 495 | $0 |
|
| 3 | HIGH CARE HOSPICE, INC. Riverside, CA, ranked 923 | $4.9M |
|
| 3 | AGAPE GROUP, INC Corona, CA, ranked 946 | $2.8M |
|
| 3 | RIVERSIDE CARE, INC. Riverside, CA, ranked 1070 | $844K |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.